Enanta Pharmaceuticals Chief Financial Officer Paul Mellett Dies

Dow Jones
09/03
 

By Colin Kellaher

 

Enanta Pharmaceuticals's long-time chief financial officer, Paul Mellett Jr., has died.

Mellett, who was 70 years old, joined Enanta as finance chief in 2003 and helped lead the Watertown, Mass., biotechnology company's initial public offering in 2013.

Enanta in late August said Harry Trout III, vice president of finance, would serve as interim principal financial officer and Kathleen Capps, executive director of accounting and controller, would step in as interim principal accounting officer while Mellett took a medical leave of absence.

 

Write to Colin Kellaher at colin.kellaher@wsj.com

 

(END) Dow Jones Newswires

September 03, 2025 06:24 ET (10:24 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10